Filing Flows › Consumer Staples › Axil Brands (AXIL)
Axil Brands (AXIL) earnings and revenue breakdown
Latest: Q1 FY27 · 10-Q filed Oct 6, 2026 · Axil Brands (AXIL) Q1 FY27 earnings results →
Q1 FY27 Revenue down 11% year over year to $6.1M · 7¢ of every $1 of revenue kept as net profit · operating margin 7.2%
Axil Brands made $6.1M in Q1 FY27 (-11% Y/Y): Direct to consumer $3.9M, Retail and wholesale $2.2M, Marketing Services $20K. Operating margin 7.2%, net earnings $421K. See where every dollar goes — costs, profit and cash — as a Sankey from the 10-Q filed Oct 6, 2026.
Drawing the Sankey…
Open the interactive Sankey → click any line for what the company wrote about it, compare Y/Y and Q/Q, export as PNG or PDF
What changed this quarter
Revenue was $6.1M in Q1 FY27, down 11% year over year and down 29% from the previous quarter. Direct to consumer was the largest line at 64% of revenue. Retail and wholesale lost $754K year over year (down 26%), 98% of the total change.
Gross margin was 82.6%, up 15.0 points from Q1 FY26. Operating profit was $437K, a 7.2% margin (up 1.2 points year over year). Operating expenses grew 9% against a revenue fall of 11%. The fastest-growing cost line was Other operating costs (+110%). Net earnings were $421K, up 26% year over year. The effective tax rate was 19.1%.
Operating cash flow was $3.8M, 895% of net earnings. Non-cash charges added back $66K of depreciation and amortization and $322K of share-based compensation. Working capital and other items added $3.0M. Capital expenditures of $165K left free cash flow of $3.6M.
Quarterly history
| Quarter | Form | Filed | Revenue | Y/Y | Op. margin | Net earnings | Op. cash flow |
|---|---|---|---|---|---|---|---|
| Q1 FY27 | 10-Q | Oct 6, 2026 | $6.1M | -11% | 7.2% | $421K | $3.8M |
| Q4 FY26 | 10-K | Aug 18, 2026 | $8.6M | +49% | 16.9% | $1.5M | −$800K |
| Q3 FY26 | 10-Q | Apr 8, 2026 | $7.3M | +5% | 2.9% | $203K | $595K |
| Q2 FY26 | 10-Q | Jan 8, 2026 | $8.1M | +5% | 11.1% | $705K | $935K |
| Q1 FY26 | 10-Q | Oct 7, 2025 | $6.9M | +17% | 6.0% | $334K | −$739K |
| Q4 FY25 | 10-K | Aug 21, 2025 | $5.8M | -12% | 0.8% | −$246K | $194K |
| Q3 FY25 | 10-Q | Apr 8, 2025 | $6.9M | +7% | 8.4% | $577K | −$170K |
Charts
Interactive views
The same charts as the app — open one to draw it.
💵Where each $1 goesinteractive
Loading the interactive chart…
🌏Named in Asian annual reportsinteractive
Loading the interactive chart…
🔄Rotation against the market and its industry (RRG)interactive
Loading the interactive chart…
🔍Earnings qualityinteractive
Loading the interactive chart…
⚖️Fair value by methodinteractive
Loading the interactive chart…
🔭Outlook & guidanceinteractive
Loading the interactive chart…
📈Investments: gains and what it boughtinteractive
Loading the interactive chart…
🏭Its industry’s money flow (input-output)interactive
Loading the interactive chart…
About Axil Brands
AXIL is engaged in the manufacturing, marketing, sale, and distribution of high tech hearing and audio enhancement and protection products, professional quality hair and skin care products, and the delivery of marketing services. The Company changed its name from Reviv3 Procare Company to AXIL Brands, Inc. effective February 14, 2024 and concurrently uplisted to the NYSE American stock exchange. The Company operates through its subsidiaries, AXIL Distribution Company (formerly Reviv3 Acquisition Corporation), Reviv3 ProCare Company, which was incorporated on February 24, 2026, and Sharper Vision Marketing Inc., which was incorporated on May 5, 2025. In February 2026, the Company formed Reviv3 ProCare Company, a wholly owned Delaware subsidiary, to support the strategic development of its Reviv3 hair and skin care business.
In its own words, from its 10-K, filed Aug 18, 2026.
Axil Brands against its Perfumes, Cosmetics & Other Toilet Preparations peers
The largest companies of the same SEC industry, each at its latest quarter. Revenue growth: -11% against the peers' median +2%. Operating margin: 7.2% against the peers' median 11.0%.
| Company | Quarter | Revenue | Y/Y | Op. margin |
|---|---|---|---|---|
| AXIL Axil Brands | Q1 FY27 | $6.1M | -11% | 7.2% |
| CL Colgate Palmolive | Q3 2026 | $5.4B | +5% | 20.3% |
| KVUE Kenvue | Q3 2026 | $3.9B | +3% | 18.2% |
| EL Estee Lauder Companies | Q1 FY27 | $3.7B | +7% | 11.0% |
| COTY Coty | Q1 FY27 | $1.6B | -1% | 11.0% |
| EPC Edgewell Personal Care | Q3 FY26 | $570M | +2% | 4.4% |
| ELF e.l.f. Beauty | Q2 FY27 | $521M | +51% | 10.1% |
| IPAR Interparfums | Q3 2026 | $430M | 0% | 27.4% |
| SLSN Solesence | Q2 2026 | $15.3M | -25% | 0.8% |
Source: Axil Brands 10-Q on SEC EDGAR · CIK 1718500 · Perfumes, Cosmetics & Other Toilet Preparations
13F: who owns AXIL and who is buying
More on AXIL
History
Every quarter: Q1 FY27 results · Q4 FY26 results · Q3 FY26 results · Q2 FY26 results · Q1 FY26 results · Q4 FY25 results · Q3 FY25 results